Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Hodgkin lymphomas that are indolent have been linked to psychological distress.

2.

Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

3.

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

4.

PRO Data Strengthen Case for Dato-DXd in First-Line TNBC

5.

Can the way we talk about cancer change how we interact with the disease?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot